window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Alzheimer’s Disease

  • Artificial Intelligence,Clinical Trials,Patient Centricity,Precision medicine,Technology and platforms

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    July 28, 2025
  • Clinical Development,Clinical Trials,Patient Centricity,Technology and platforms

    Linus Health to showcase AI tools for brain health detection and trial recruitment at AAIC 2025

    Linus Health will present new findings on its AI-driven cognitive [...]

    July 23, 2025
  • Partnerships & Funding

    PacBio Joins Davos Alzheimer’s collaborative to expand dementia research in North Africa

    PacBio has been selected as a technology partner by the [...]

    April 25, 2025
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top